Report #2873188

Overview

Sex

Unknown

Age

Age unknown

State

—

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

Inappropriate age at vaccine administration; This non-serious case was reported by a other health professional via sales rep and described the occurrence of inappropriate age at vaccine administration in a 58-year-old patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis. Concurrent medical conditions included chronic obstructive pulmonary disease and immunocompromised. On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced inappropriate age at vaccine administration (Verbatim: Inappropriate age at vaccine administration). The outcome of the inappropriate age at vaccine administration was not applicable. Additional Information: GSK Receipt Date: 11-NOV-2025 The batch number was not provided and a request for this information has been made.

Current illness

Chronic obstructive pulmonary disease; Immunocompromised